.AN2 Therapies is reassessing its business in feedback to lackluster midphase information, promising...
.Merck & Co. is actually paying out $700 million in advance to test Amgen in a blood stream cance...
.Along With Gilead Sciences on the verge of an FDA decision for its own liver health condition medic...
.CEO David Ricks can easily view the providers putting together tents at basecamp behind Eli Lilly i...
.Bed Liquidators has transformed Entero Therapeutics white as a sheet. The lender bought Entero to s...
.Exelixis is surrendering on its tissue factor (TF)- targeting antibody-drug conjugate after conclud...
.3 weeks after Roche's Genentech system bowed out an SHP2 inhibitor contract, Relay Therapeutics has...
.Stoke Therapeutics' Dravet disorder medication has been devoid of a predisposed hold, clearing the ...
.Brutal Biotech Partner Publisher Gabrielle Masson offered the 2024 class of Strong 15 victors on th...
.Novo Nordisk has actually axed its own once-monthly double GLP-1/ GIP receptor agonist, finishing (...